Company intelligence / Profile preview

XARlabs

London, United Kingdomxarlabs.ai ↗

Ownership: Private
Development stage: Preclinical

Overview

XARlabs has developed simXAR, a mixed reality software that transforms traditional medical imaging into immersive 3D simulations for surgical planning, education, and patient consent. The technology has been successfully integrated at NHS hospitals and was pivotal in the planning of a groundbreaking conjoined twins separation surgery. The company’s solutions are recognized for their precision, realism, trackerless marking capability, on-device rendering, and global accessibility.

Therapeutic areas: Other
Modalities: DeviceSoftware platform (Mixed reality surgical simulation)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on XARlabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on XARlabs.

Explore the full profile